1372-C NON-LINEAR ASSOCIATION OF BASELINE VIRAL LOAD WITH ON-TREATMENT HEPATOCELLULAR CARCINOMA RISK IN CHRONIC HEPATITIS B Won-Mook Choi 1 , Gi-Ae Kim 2 , Jonggi Choi 3 , Gwang Hyeon Choi 4 , Yun Bin Lee 5 , Dong Hyun Sinn 6 and Young-Suk Lim 1 , (1)Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South), (2)Kyung Hee University School of Medicine, (3)Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, (4)Seoul National University Bundang Hospital, Seoul National University College of Medicine, (5)Seoul National University College of Medicine, (6)Samsung Medical Center Background: The association between baseline pre-treatment serum hepatitis B virus (HBV) DNA levels and on-treatment hepatocellular carcinoma (HCC) risk remains controversial in chronic hepatitis B (CHB) patients

The effects of GLP-1RAs on prostate cancer risk Preclinical studies have demonstrated that GLP-1RAs are capable of inhibiting the proliferation of prostate cancer cells in both in vivo and in vitro experiments, thereby suggesting potential preventative effects [36]
We handle the vetting of pharmacies, the consultations, the dosing strategy, and the ongoing support
Semaglutide monotherapy also significantly improved fasting glucose (Fig